Literature DB >> 21331203

Collaborative cardiac care service: a multidisciplinary approach to caring for patients with coronary artery disease.

Brian G Sandhoff, Susan Kuca, Jon Rasmussen, John A Merenich.   

Abstract

BACKGROUND: Coronary artery disease (CAD) remains the leading cause of death in the US. In 1996, Kaiser Permanente of Colorado (KPCO) developed the Collaborative Cardiac Care Service (CCCS) with the goal of improving the health of patients with CAD. DESCRIPTION: CCCS consists of a nursing team (the KP Cardiac Rehabilitation program) and a pharmacy team (the Clinical Pharmacy Cardiac Risk Service). CCCS works collaboratively with patients, primary care physicians, cardiologists, and other health care professionals to coordinate proven cardiac risk reduction strategies for patients with CAD. Activities such as lifestyle modification, medication initiation and adjustment, patient education, laboratory monitoring, and management of adverse events are all coordinated through CCCS. The CCCS uses an electronic medical record and patient-tracking software to document all interactions with patients, track patient appointments, and collect data for evaluation of both short- and long-term outcomes. OUTCOMES: The CCCS currently follows over 12,000 patients with CAD. The CCCS has demonstrated improvement in surrogate outcomes including: cholesterol screening (55% to 96.3%), the proportion of patients with a goal of low-density lipoprotein cholesterol (LDL-c) <100 mg/dL (22% to 76.9%), and has reduced the average LDL-c to 78.3 mg/dL for the CAD population it follows. The CCCS has shown a reduction in all-cause mortality associated with CAD by 76% in the patients followed by the service. Patient and physician satisfaction have been high with CCCS.
CONCLUSION: The CCCS coordinates many aspects of cardiac risk reduction care resulting in excellent continuity of care. The CCCS has continued to grow and expand the number of patients enrolled by using innovative strategies and technology and has resulted in excellent care and improved outcomes of the CAD population at KPCO.

Entities:  

Year:  2008        PMID: 21331203      PMCID: PMC3037123          DOI: 10.7812/TPP/08-007

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  22 in total

1.  Treatment of hypertension in adults with diabetes.

Authors:  Carlos Arauz-Pacheco; Marian A Parrott; Philip Raskin
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

Review 2.  Cholesterol risk management: a systematic examination of the gap from evidence to practice.

Authors:  K L Olson; T J Bungard; R T Tsuyuki
Journal:  Pharmacotherapy       Date:  2001-07       Impact factor: 4.705

3.  Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.

Authors:  Nicolas Danchin; Michel Cucherat; Christian Thuillez; Eric Durand; Zena Kadri; Philippe G Steg
Journal:  Arch Intern Med       Date:  2006-04-10

4.  A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years.

Authors:  Jennifer G Robinson; Nidhi Maheshwari
Journal:  Am J Cardiol       Date:  2005-02-01       Impact factor: 2.778

5.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

6.  Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization.

Authors:  Kari L Olson; Jon Rasmussen; Brian G Sandhoff; John A Merenich
Journal:  Arch Intern Med       Date:  2005-01-10

7.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

8.  Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

Authors: 
Journal:  N Engl J Med       Date:  1998-11-05       Impact factor: 91.245

9.  Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease.

Authors:  John A Merenich; Kari L Olson; Thomas Delate; Jon Rasmussen; Dennis K Helling; David G Ward
Journal:  Pharmacotherapy       Date:  2007-10       Impact factor: 4.705

10.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Authors:  Wayne Rosamond; Katherine Flegal; Karen Furie; Alan Go; Kurt Greenlund; Nancy Haase; Susan M Hailpern; Michael Ho; Virginia Howard; Brett Kissela; Bret Kissela; Steven Kittner; Donald Lloyd-Jones; Mary McDermott; James Meigs; Claudia Moy; Graham Nichol; Christopher O'Donnell; Veronique Roger; Paul Sorlie; Julia Steinberger; Thomas Thom; Matt Wilson; Yuling Hong
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

View more
  7 in total

1.  Assessment of Pharmacy Department Patient Safety Culture with the Use of Validated Work Environment Survey Indices.

Authors:  Julia E Rawlings; Sheryl J Herner; Thomas Delate; Kelsey E Palmer; Kelly A Swartzendruber
Journal:  Perm J       Date:  2018

2.  Investing in Health IT: A Stimulus for a Healthier America.

Authors:  John H Cochran
Journal:  Perm J       Date:  2009

3.  Proposed method for evaluation and categorization of functional capacity of children, adolescents, and adults with cardiac diseases to bring them in existing social justice system by creating the cardiac disability criteria.

Authors:  Smita Mishra; Rajesh Sharma
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-24

4.  Primary care multidisciplinary teams in practice: a qualitative study.

Authors:  Brandi Leach; Perri Morgan; Justine Strand de Oliveira; Sharon Hull; Truls Østbye; Christine Everett
Journal:  BMC Fam Pract       Date:  2017-12-29       Impact factor: 2.497

5.  Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk-management gaps among a primary-prevention population compared with a propensity-matched primary-care cohort: A team-based care model and its impact on lipid and blood pressure management.

Authors:  Emilio Fentanes; Anthony G Vande Hei; R Scott Holuby; Norma Suarez; Yousif Slim; Jennifer N Slim; Ahmad M Slim; Dustin Thomas
Journal:  Clin Cardiol       Date:  2018-06-05       Impact factor: 2.882

6.  Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3-5 in Taiwan.

Authors:  Yung-Ho Hsu; Wu-Chien Chien; Chu-Lin Chou; Chi-Hsiang Chung; Hui-Wen Chiu; Chia-Te Liao; Chia-Chao Wu
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

7.  Perceived Preparedness of Health Care Students for Providing Cardiovascular Disease Risk Assessment and Management.

Authors:  Monica Zolezzi; Oraib Abdallah; Suad Aden; Stella Major; Diana White; Alla El-Awaisi
Journal:  Pharmacy (Basel)       Date:  2017-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.